搜索临床试验以:烟熏大麻
总计689个结果
-
Rutgers, The State University of New JerseyNational Institute on Drug Abuse (NIDA)完全的
-
Ludwig-Maximilians - University of MunichGerman Federal Ministry of Education and Research; CareFusion未知
-
McMaster UniversityInternational Society on Thrombosis and Haemostasis招聘中
-
Chinese University of Hong KongNorth District Hospital; King Chulalongkorn Memorial Hospital; Changi General Hospital完全的
-
Uppsala UniversityThe Kamprad Family Foundation for Entrepreneurship, Research & Charity招聘中
-
Vanderbilt University Medical CenterSociety of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction; The Allergan Foundation终止
-
Peking Union Medical College HospitalCSPC Ouyi Pharmaceutical Group Co., Ltd.尚未招聘
-
Hunan Province Tumor Hospital招聘中
-
Medlab ClinicalGeorge Clinical Pty Ltd; WriteSource Medical Pty Ltd尚未招聘
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)终止
-
CIPRA SANational Institute of Allergy and Infectious Diseases (NIAID)完全的
-
Humanitas Clinical and Research CenterSocieta Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva招聘中
-
Medical Center AlkmaarAalborg University; VU University of Amsterdam; Technical University of Twente; Rudolf Magnus Institute... 和其他合作者完全的
-
Astellas Pharma Global Development, Inc.主动,不招人白血病,急性髓系 (AML)日本, 美国, 比利时, 加拿大, 法国, 德国, 以色列, 意大利, 大韩民国, 波兰, 西班牙, 台湾, 火鸡, 英国
-
Coxa, Hospital for Joint Replacement未知
-
Tanta University完全的
-
Centers for Disease Control and PreventionAIDS Clinical Trials Group未知
-
Stanford UniversityNational Cancer Institute (NCI)完全的
-
University of NebraskaNational Cancer Institute (NCI)完全的胰腺癌 | III期胰腺癌 | IIA期胰腺癌 | IIB期胰腺癌 | II期胰腺癌 | I期胰腺癌 | 可切除的胰腺癌 | IA 期胰腺癌 | IB 期胰腺癌美国
-
Jonsson Comprehensive Cancer Center完全的
-
David Bond, MD招聘中复发性原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 难治性原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 伴有 MYC、BCL2 和 BCL6 重排的复发性高级别 B 细胞淋巴瘤 | 具有 MYC、BCL2 和 BCL6 重排的难治性高级 B 细胞淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤,未另行说明 | 伴有 MYC 和 BCL2 或 BCL6 重排的复发性高级别 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤,未另行说明 | 具有 MYC 和 BCL2 或 BCL6 重排的难治性高级 B 细胞淋巴瘤 | 复发性转化滤泡性淋巴瘤至弥漫性大 B 细胞淋巴瘤 | 难治性转化滤泡性淋巴瘤至弥漫性大 B 细胞淋巴瘤 | 复发性 3b 级滤泡性淋巴瘤 | 难治性 3b 级滤泡性淋巴瘤 及其他条件美国
-
National Cancer Institute (NCI)主动,不招人